Kevin E. Lofton - 03 May 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Director
Signature: /s/ Amy Kim by Power of Attorney for Kevin E. Lofton
Issuer symbol: GILD
Transactions as of: 03 May 2022
Net transactions value: $0
Form type: 4
Filing time: 03 May 2022, 20:07:12 UTC
Previous filing: 04 May 2022
Next filing: 06 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+2,223	+2.5%		92,748	03 May 2022	By Trust	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-2,223	-18%		9,830	03 May 2022	Common Stock	2,223		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	Includes 63,430 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust.
F3	100% of the restricted stock units vested on May 3, 2022.